Skip to main content

Neurocognitive Disorder clinical trials at UCSF

3 in progress, 1 open to eligible people

Showing trials for
  • Brain Health Together: A Live-Streaming Group-Based Digital Program

    open to eligible people ages 55-85

    The purpose of this study is to develop and test a comprehensive Brain Health Together program for older adults living with cognitive decline.

    San Francisco, California

  • Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

    Sorry, in progress, not accepting new patients

    The purpose of this study is to test whether an investigational drug called solanezumab can slow the progression of memory problems associated with brain amyloid (protein that forms plaques in the brains of people with Alzheimer Disease [AD]).

    San Francisco, California and other locations

  • Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

    Sorry, in progress, not accepting new patients

    The Innovative Support for Patients with SARS COV-2 Infections Registry (INSPIRE) study is a CDC-funded COVID-19 project to understand the long-term health outcomes in recently tested adults, both negative and positive, who have suspected COVID symptoms at the time of their test. Participants will complete short online surveys every 3 months for 18 months, share information about their health using a secure web-based platform, and are compensated for their time.

    San Francisco, California and other locations

Our lead scientists for Neurocognitive Disorder research studies include .

Last updated: